Item 5.02 Departure of Directors or Certain Officers; Election of Directors;


          Appointment of Certain Officers; Compensatory Arrangements of Certain
          Officers

On January 23, 2020, Blonder Tongue Laboratories, Inc. (the "Company") appointed John Burke as a director. Mr. Burke has served since 2017 as a Managing Partner of Vetust Advisors, which provides strategic and management consulting services to a variety of businesses. He previously served as Executive Vice President and Chief Operating Officer of Rovi Corporation (since re-named TiVo) from 2014 to 2016, where he led the transformation of the company's content discovery, user interface, and data analytics businesses, including the acquisition of TiVo. Prior to joining Rovi, Mr. Burke led a number of different businesses for ARRIS Group, Motorola, Motorola Mobility and General Instrument. He holds a Bachelor of Science in Business Administration from The Ohio State University, a Masters of Business Administration from St. Joseph's University and attended the Executive Leadership Program at Northwestern University's Kellogg School of Business.

Mr. Burke will serve as a director in Class II, with a term expiring at the Company's annual meeting of stockholders in 2021. Mr. Burke's board of directors committee assignments have not yet been determined. The Company's board of directors has determined that Mr. Burke meets the requirements for independence under applicable Securities and Exchange Commission and NYSE American rules and standards. There are no arrangements or understandings pursuant to which Mr. Burke was appointed as a director, and there are no related party transactions between the Company and Mr. Burke reportable under Item 404(a) of Regulation S-K. In connection with his service as a director, Mr. Burke will be entitled to the same compensation and benefits made available to the Company's non-employee directors generally, pro-rated for the term of his service during calendar year 2020.

A copy of the press release announcing Mr. Burke's appointment is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits. The following exhibit is filed herewith:






Exhibit No.   Description

   99.1         Press Release dated January 27, 2020.




                                       1

© Edgar Online, source Glimpses